ALLK: Allakos Inc. Stock

by  •  • Comments Off on ALLK: Allakos Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 23.23
Enterprise Value ($M) 12.78
Book Value ($M) 72.74
Book Value / Share 0.81
Price / Book 0.32
NCAV ($M) 45.46
NCAV / Share 0.51
Price / NCAV 0.51

Profitability (mra)
Return on Invested Capital (ROIC) -1.60
Return on Assets (ROA) -0.73
Return on Equity (ROE) -1.06

Liquidity (mrq)
Quick Ratio 6.08
Current Ratio 6.08

Balance Sheet (mrq) ($M)
Current Assets 97.15
Assets 124.43
Liabilities 51.69
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-03 13D Tang Capital Management Llc 9.70
11-12 13G Fmr Llc 6.04 279.40
07-08 13G/A BlackRock, Inc. 1.40 -75.23
2024-02-14 13G/A Logos Global Management LP 3.30 -45.15
2024-02-14 13G/A Deep Track Capital, LP 2.87 -49.79
2024-02-14 13G/A Citadel Advisors Llc 3.80
2024-02-12 13G Price T Rowe Associates Inc /md/ 9.10

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One)
2024-08-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One)
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One)
2024-03-14 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One)

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-10 218,518 733,134 29.81
2025-03-07 119,631 383,576 31.19
2025-03-06 161,984 799,169 20.27
2025-03-05 119,830 853,285 14.04

(click for more detail)

Similar Companies
AKRO – Akero Therapeutics, Inc. ALEC – Alector, Inc.
ALKS – Alkermes plc ALLO – Allogene Therapeutics, Inc.
ALNY – Alnylam Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io